Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
Clinical trial NCT07138144 · RECRUITING
Trial details
- NCT number
- NCT07138144
- Sponsor
- José Antonio Mata Marín
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-12
- Primary completion
- 2026-02-28
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.